Tympanic paragangliomas: a large case series and single institutional experience

Authors:

Abstract
Background: Head and neck paragangliomas (HNPGs), of which tympanic paragangliomas (TPGs) or glomus tympanicums are a subset, are rare and complex tumors. Our understanding of HNPGs is rapidly evolving especially in relation to the genetic basis of this disease. This study aims to review the clinicopathologic factors and treatment outcomes of a large series of TPGs to help inform future treatment decision making. Methods: Guy’s and St Thomas’ Hospital Trust maintains a prospective database of HNPGs. A clinical review of this database was performed from 1984 until 2019. There were 349 cases of HNPGs. After applying inclusion and exclusion criteria there were a total of 56 cases with a clinical or pathologic diagnosis of a tympanic paraganglioma suitable for analysis. Results: The average age at presentation was 53.4 years (SD ±13.1), with a male to female ratio of 1:17.7. There were genetic mutations or variants of uncertain significance (VUS) associated with TPGs found in four (7.1%) patients. Five (8.9%) patients with TPGs had multiple paragangliomas. Of all patients with TPGs, three (5.4%) had other HNPGs and two (3.6%) had other non-HNPGs. The difference in median pre- and post-operative air conduction (AC) threshold and bone conduction (BC) thresholds was a 7 dBHL and 1 dBHL improvement respectively. Progression free survival or treatment failure was calculated for TPGs with progression free survival probability at 5 years: 0.93 (95% CI: 0.73–0.98), and at 10 years: 0.88 (95% CI: 0.68–0.96). Conclusions: Improved understanding of TPGs will lead to better assessment, management and patient outcomes. Level of Evidence: Level IV.

This publication has 39 references indexed in Scilit: